fda glp-1 warning letters november 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns – Partnership for Safe Medicines Report: FDA must enforce rules

If you have concerns with how much weight you are losing, or if you feel like you are not losing enough, consult with your provider to see what changes can be made

There were no significant associations between the receptor expression status and the clinicopathological features

GLP-1 agonist Liraglutide prevents MK801-induced schizophrenialike behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice

OptioRx (HQ Columbus, OH) filed Chapter 11 bankruptcy in June/July 2024 and continues operating under restructuring

Bariatric Surgery: Metabolic and bariatric surgery should be considered for patients with BMI 40 kg/m or 35 kg/m with obesity-related comorbidities